The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice

We have investigated to develop novel vaccines against SARS CoV using cDNA constructs encoding the structural antigen; spike protein (S), membrane protein (M), envelope protein (E), or nucleocapsid (N) protein, derived from SARS CoV. Mice vaccinated with SARS-N or -M DNA using pcDNA 3.1(+) plasmid v...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Masaji, Takemoto, Yuji, Okuno, Yoshinobu, Hashimoto, Satomi, Yoshida, Shigeto, Fukunaga, Yukari, Tanaka, Takao, Kita, Yoko, Kuwayama, Sachiko, Muraki, Yumiko, Kanamaru, Noriko, Takai, Hiroko, Okada, Chika, Sakaguchi, Yayoi, Furukawa, Izumi, Yamada, Kyoko, Matsumoto, Makoto, Kase, Tetsuo, deMello, Daphne E., Peiris, J.S.M., Chen, Pei-Jer, Yamamoto, Naoki, Yoshinaka, Yoshiyuki, Nomura, Tatsuji, Ishida, Isao, Morikawa, Shigeru, Tashiro, Masato, Sakatani, Mitsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2005
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115605/
https://www.ncbi.nlm.nih.gov/pubmed/15755609
http://dx.doi.org/10.1016/j.vaccine.2005.01.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115605/
https://www.ncbi.nlm.nih.gov/pubmed/15755609
http://dx.doi.org/10.1016/j.vaccine.2005.01.036

Ejemplares similares